CD209 in inflammatory bowel disease: a case-control study in the Spanish population
2007

CD209 and Inflammatory Bowel Disease in Spain

Sample size: 1743 publication Evidence: moderate

Author Information

Author(s): Concepción Núñez, Javier Oliver, Juan Luis Mendoza, María Gómez-García, Carlos Taxonera, Luis M Gómez, Miguel A López-Nevot, Emilio G de la Concha, Elena Urcelay, Alfonso Martínez, Javier Martín

Primary Institution: Hospital Clínico San Carlos, Madrid, Spain

Hypothesis

Is the CD209 gene variant associated with susceptibility to Inflammatory Bowel Diseases in the Spanish population?

Conclusion

The CD209 gene variant does not influence Crohn's disease susceptibility but may increase the risk of Ulcerative Colitis in certain individuals.

Supporting Evidence

  • The study involved 515 CD patients, 497 UC patients, and 731 healthy controls.
  • No initial association was found between CD209 and UC or CD.
  • Stratification by HLA-DR3 showed increased susceptibility in HLA-DR3-positive individuals.
  • The CD209_G allele was associated with increased risk in HLA-DR3-positive UC patients.

Takeaway

Scientists studied a gene to see if it makes people more likely to get a type of stomach sickness. They found it might only affect some people.

Methodology

A case-control study with genotyping of the CD209 SNP rs4804803 in patients and healthy controls.

Limitations

The association with CD209 and Ulcerative Colitis was only observed in a specific subgroup, and further studies are needed.

Participant Demographics

515 Crohn's disease patients, 497 ulcerative colitis patients, and 731 healthy controls, all of Spanish white origin.

Statistical Information

P-Value

0.03

Confidence Interval

95% CI 1.04–3.02

Statistical Significance

p = 0.03

Digital Object Identifier (DOI)

10.1186/1471-2350-8-75

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication